Clinical Manufacturing Services Market by Finished Dosage Formulations (Tablets, Capsules, Oral Dosages), Type (Analytical Services, Formulation Development, Stability/Storage), End-User (Pharmaceuticals Biopharmaceuticals) - Global Forecast to 2023
In the face of limited resources, the pharmaceutical companies have been recently focusing on the areas of their core competency in drug research and development. The capital-intensive nature of pharmaceutical drug R&D activities have created a need to outsource clinical stage manufacturing of drugs. Clinical manufacturing services include development of formulations for clinical trials, analysis of those formulations and their solubility and stability testing services.
The major factor driving the growth of clinical manufacturing services market is the state-of-art manufacturing process that uses high-caliber analytical tools to meet regulatory requirements. Additionally, rapidly growing discovery of new molecules, rising number of clinical trials, increasing funding and government support towards developing new drugs, and availability of advanced analytical technology to speed up the clinical phase in drug development are some of the factors driving the growth of this market. On the other hand, stringent regulations, and increasing logistics costs are some of the factors restraining the growth of this market.
The report provides an overall understanding of the global clinical manufacturing services market. This report segments the market on the basis of finished dosage formulations (FDF), services, end-user, and region. On the basis of end-user, the market is segmented into pharmaceuticals and biopharmaceuticals. On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
A combination of bottom-up and top-down approaches will be used to calculate the market sizes and growth rates of the global clinical manufacturing services market and its subsegments. All percentage shares, splits, and breakdowns are determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study will be taken into account, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders will also be used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Target audience for this report:
- Pharmaceutical Drug Manufacturers
- Clinical Research Organizations
- Contract Manufacturing Organizations (CMO)
- Business research and consulting service providers
- Government and Academic Organizations
Table of Contents
1 Clinical Manufacturing Services Market, By Finished Dosage Formulations
1.4 Oral Formulations
1.5 Inhalation Formulations
1.5 Local Applications Such as Creams, Lotions, Ointments
1.6 Combination Drug/Device Products
1.7 Others (If Any)
2 Clinical Manufacturing Services Market, By Type
2.2 CGMP Analytical Services
2.3 Formulation Development
2.4 Clinical Stability Storage Testing
3 Clinical Manufacturing Services Market, By End-User
4 Clinical Manufacturing Services Market, By Region
4.2 North America
4.4 Asia Pacific
Growth opportunities and latent adjacency in Clinical Manufacturing Services Market